Mortality | FPG ≤5mmol/l | FPG 5–7mmol/l | FPG 7–9mmol/l | FPG ≥9.1mmol/l | ||||||||
HR | 95% CI | p Value | HR | 95% CI | p Value | HR | 95% CI | p Value | HR | 95% CI | p Value | |
All Patients | ||||||||||||
In-hospital | 1.696 | 1.026 to 2.348 | 0.035 | Reference group | 1.563 | 1.127 to 3.442 | 0.029 | 2.284 | 1.668 to 4.006 | 0.003 | ||
3-Year | 1.334 | 1.021 to 2.089 | 0.048 | 1.622 | 1.131 to 4.562 | 0.006 | 2.016 | 1.537 to 3.980 | 0.012 | |||
Patients with DM | ||||||||||||
In-hospital | 2.178 | 1.003 to 1.562 | 0.037 | Reference group | 0.951 | 0.872 to 1.138 | 0.289 | 0.970 | 0.796 to 1.993 | 0.098 | ||
3-Year | 2.296 | 1.153 to 3.080 | 0.024 | 1.145 | 1.098 to 2.055 | 0.006 | 3.556 | 1.918 to 9.147 | 0.002 | |||
Patients without DM | ||||||||||||
In-hospital | 1.140 | 0.863 to 4.962 | 0.414 | Reference group | 2.287 | 1.395 to 4.433 | 0.002 | 3.137 | 1.838 to 6.002 | <0.001 | ||
3-Year | 1.030 | 0.611 to 2.256 | 0.183 | 1.984 | 1.129 to 4.562 | 0.031 | 1.550 | 1.273 to 3.075 | 0.003 | |||
Medicine Group | ||||||||||||
In-hospital | 2.162 | 1.778 to 5.589 | 0.002 | Reference group | 2.304 | 1.176 to 3.338 | 0.020 | 3.153 | 2.449 to 7.678 | <0.001 | ||
3-Year | 3.391 | 2.580 to 9.711 | 0.011 | 2.253 | 1.198 to 3.057 | 0.029 | 2.899 | 2.372 to 6.994 | 0.002 | |||
PCI group | ||||||||||||
In-hospital | 1.003 | 0.813 to 1.114 | 0.689 | Reference group | 1.103 | 0.895 to 1.449 | 0.262 | 1.562 | 1.033 to 2.174 | 0.041 | ||
3-year | 1.152 | 1.009 to 2.367 | 0.034 | 1.258 | 1.014 to 3.559 | 0.027 | 1.508 | 1.010 to 2.362 | 0.047 | |||
CABG group | ||||||||||||
In-hospital | 3.011 | 2.552 to 7.961 | <0.001 | Reference group | 0.998 | 0.893 to 1.141 | 0.452 | 1.105 | 0.973 to 2.667 | 0.088 | ||
3-year | 2.540 | 2.078 to 6.859 | <0.001 | 1.782 | 1.236 to 3.159 | 0.022 | 2.003 | 1.727 to 5.679 | 0.003 |
CABG, coronary artery bypass graft; DM, diabetes mellitus; HR, hazard ratio; PCI, percutaneous coronary intervention.